Robert Garland, MD

Venture Partner, Menlo Park

Robert joined NEA in 2003 and invests in biopharmaceuticals.  He is a director of Cleave Biosciences, and Surface Oncology. Prior to NEA, in addition to clinical practice at the University of California, San Francisco (UCSF), he was with McKinsey & Company's Pharmaceutical & Medical Products and Corporate Finance & Strategy practices. Robert completed his Residency in Internal Medicine and Fellowship in Infectious Diseases at UCSF and received his MBA and MPH from the University of California, Berkeley, his MD from Baylor College of Medicine, and his BS in Electrical Engineering/Bioengineering from Rice University.